Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal bupivacaine versus magnesium sulfate versus saline after laparoscopic sleeve gastrectomy
IRCT20230129057271N2Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of bupivacaine, magnesium sulfate and sodium chloride in postoperative pain and postoperative nausea and vomiting (PONV) (3 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Postoperative surgical site pain, Postoperative shoulder pain and 2 more. Started May 2025; status: completed.
02
Drugs
bupivacainemagnesium sulfatesodium chloride
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20230129057271N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230129057271N2.